Новости за 11.11.2016

Two of Russia's largest banks, Sberbank and Alfa Bank, say they have been hit by cyber attacks in recent days.

The clinical-stage biotech's revenue soars in Q3 thanks to Celgene exercising licensing rights on the CD19 program.

Investors were impressed with Sunrun Inc.'s growth last quarter, but there's a concerning number deep within the results.

President Trump could be bad news for solar. But this news could be worse.

Everyones talking about this emerging tech revolution.

Brazilian water utility Companhia de Saneamento Basico do Estado de Sao Paulo -- Sabesp, for short -- is starting to hit its stride again now that weather and forex headwinds have eased.

Drugmaker Pfizer says it's reducing what it charges humanitarian groups for its blockbuster vaccine against pneumonia, ear and blood infections.

The company notified the SEC that it will be filing its quarterly report late after errors were discovered, but it may not be as bad as it appears.

Starbucks' stock may be down this year, but its underlying business is growing handsomely.

A recommendation for EU renewal of the Duchenne muscular dystrophy drug Translarna is sending shares soaring.

Shares tumbled after management poured cold water on the company's long-term growth targets.

IBM, Baidu, and Apple are all trading at discounts to the overall market.

The craft beer specialist fell as investors worried over the results of its competitors. Here's what investors need to know.

Uranium is Camecos business, but investors might be surprised at how important a role Asia plays in this miners future.

Detroit has a checkered past when it comes to fleet sales, but Fiat Chrysler Automotive is wisely reducing its reliance on them.

With some of Merck's best-selling drugs set to lose exclusivity soon, should investors remain patient with this big pharma stock or hit the exits? Here is what two of our regulator healthcare contributors had to say.

Though market conditions took a turn for the worse in the third quarter, the rendering and biodiesel company admirably took it in stride.

J.C. Penney Co. Inc. shares sank 7.3% in Friday premarket trading after the retailer reported a third-quarter sales miss.

A proposed combination of two of the largest cigarette companies may look compelling, but there's more to the story for investors to consider.

A little effort on your part could lead to enormous benefits down the road.

Unprecedented steps by Beijing to snuff out a months-long rally in coal prices are casting fresh doubts on China's drive to become a global price-setting hub for commodities worth trillions of dollars.

Asian shares were mixed Friday and the dollar recovered, but expectations grew that President-elect Donald Trump's trade policies might fuel inflation, even as some of the initial jitters have subsided.

The graphics specialist is making huge inroads in unfamiliar markets such as the data center and automotive computing.

The company has had success with its marquee game release this fall. Should investors buy in because of the hype?

Everyones talking about this emerging tech revolution.